What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing disease

J. Kuhle, A.F.S. Petzold

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)393-410
JournalExpert Opinion on Medical Diagnostics
Volume5
Issue number5
DOIs
Publication statusPublished - 2011

Cite this

@article{e096e6b21b6d46e8841c3123637b2702,
title = "What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing disease",
author = "J. Kuhle and A.F.S. Petzold",
year = "2011",
doi = "10.1517/17530059.2011.592184",
language = "Undefined/Unknown",
volume = "5",
pages = "393--410",
journal = "Expert Opinion on Medical Diagnostics",
issn = "1753-0059",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing disease

AU - Kuhle, J.

AU - Petzold, A.F.S.

PY - 2011

Y1 - 2011

U2 - 10.1517/17530059.2011.592184

DO - 10.1517/17530059.2011.592184

M3 - Article

VL - 5

SP - 393

EP - 410

JO - Expert Opinion on Medical Diagnostics

JF - Expert Opinion on Medical Diagnostics

SN - 1753-0059

IS - 5

ER -